|
|
|
 |
Mark De Simone
Vice President, Middle East and Africa (MEA), Cisco Systems Inc. |
|
Mark De Simone
is Vice President for Cisco’s operations in the Middle East and Africa, a
position he has held since July 2004.
With
responsibility for running Cisco’s field sales operations, technical engineering
and marketing for these emerging and developing markets, De Simone is
responsible for Cisco’s business in 84 countries and Cisco operations and
offices in more than 15 countries. Working with senior government and business
leaders across the region, he is tasked with developing Cisco’s business in a
territory that has seen consistent year-over-year growth and is currently
experiencing a period of deregulation in the telecoms sector.
De Simone has
held a number of senior sales and management positions at Cisco, most recently
serving as Vice President of Market Development, Channels, Alliances and
Corporate Marketing at Cisco Systems EMEA, where he led the Market Development,
Global Systems Integrators, SP Channels, Alliances and Corporate Marketing
organizations. He joined Cisco in 2001 as the Vice President of Technology
Solutions and Corporate Marketing for Cisco Systems, EMEA.
With over 22
years industry experience he has built a strong global understanding of customer
requirements in a number of senior management roles, most recently as Executive
Vice President of Storm Telecommunications and AduroNet, two advanced services
telecommunications operators in Europe and as Vice President of Global Marketing
for Lucent Technologies. He has also served as Vice President of 3COM-US
Robotics’ European operations and spent five years with General Electric, both
in Paris and Milwaukee, Wisconsin. At GE, Mark was the VP of European Marketing
and later General Manager for the company’s Medical Network Products and
Services business.
He is a frequent
speaker at industry events throughout the Middle East and Africa and is a
regular commentator in business and broadcast media throughout the region on ICT
issues of relevance to these emerging and developing markets.
Mark is a former
McKinsey associate and has an engineering degree from Cornell University and an
MBA from Columbia University. He currently lives in London, England with his
wife and three children.
Further
information:
Cisco Corporate
PR: Tel: +44 (0) 7718 581 264, Email:
davicook@cisco.com |
 |
Prof. Vijay Chandru
Professor, Indian Institute of Science
Chairman & CEO, Strand Life Sciences |
|
Vijay Chandru (PhD MIT
1982), is an academic entrepreneur. A Professor of Computer Science at the
Indian Institute of Science, Vijay and three colleagues from the Indian
Institute of Science founded Strand Life Sciences, India's first life sciences
informatics company in October 2000. He currently serves as Chairman & Chief
Executive Officer of the company. Strand is the recipient of the Frost &
Sullivan Award for Excellence in Technology 2005 in the field of Bioinformatics.
Strand has also been selected in the Red Herring Asia 100 – a list of 100 rising
star technology companies in greater Asia.
Vijay is a co-founder and General Secretary of the
Association of Biotech led Enterprises (ABLE). He is the recipient of several
awards and honours: Hughes Fellow (1982-85), AT&T Fellow (1991-1993), elected
Fellow of Indian Academy of Sciences (1996 - ), MCIT Dewang Mehta Award for
Innovation in Information Technology (2001), University Grants Commission award
for “Science and Society” (2003), AstraZeneca Chairman’s Award for
Entrepreneurship and Innovation (2004) for contributions in computational
biology.
Keynote Title: Analytics, Modeling and
Decision Support in Drug Discovery and Development
Abstract: This talk will describe experiences, challenges and
opportunities in applying the decision sciences to target discovery, drug
discovery and development. The experiences are drawn from the speaker’s
association with an inter-disciplinary team of scientists at Strand Life
Sciences, India’s leading life sciences informatics company, a spin off from the
Indian Institute of Science in Bangalore. Technologies developed at Strand for
decision support include a very powerful data analysis and predictive
modelling platform called “avadis”. The platform has been specialized for
research biology applications particularly in the realm of gene expression
studies to support the discovery of novel targets. avadis has also been
instantiated as a modeling platform admetis for building predictive
models of drug like properties of small molecules. The predictive
chemoinformatics models become the basis for design of target focused small
molecule libraries to improve the efficiency of lead generation in drug
discovery. The same platform technology also has the potential to provide
decision support in pre-clinical and clinical phases of drug development. |
 |
Dr. Krishna Nathan
Vice President & Director of
the IBM Research Laboratory, Zurich |
|
Dr. Krishna Nathan is Vice President, Services
and Director of the IBM Zurich Research Laboratory. He joined IBM in 1991 at the
T.J. Watson Research Center, where he held various research and management
positions in pen computing, handwriting recognition, mobile and handheld
platforms and related applications. From 1999 to 2001, Dr. Nathan was director
for consumer voice systems in the software group, where he was responsible for
world-wide sales, marketing and development of IBM's consumer line of speech
products. Immediately prior to his current appointment he was Executive
Assistant to the vice-chairman of the board of IBM.
Dr. Nathan holds a doctorate in electrical
sciences from Brown University and a master's degree in electrical engineering
from the Massachusetts Institute of Technology. |
|
|
